Business Context and Reporting Period
This Form 6-K filing by IM Cannabis Corp. covers the month of January 2026. The Company, a foreign private issuer based in Israel, reported the completion of two convertible note transactions with an institutional investor to raise capital for debt repayment and general corporate purposes.
Key Financial Metrics
- Total Proceeds: US$2,171,660.40 net proceeds received from the combined offerings.
- Debt Issuance: Two convertible notes totaling US$2,413,446 in principal (US$1,709,721 in the First Transaction and US$703,725 in the Second Transaction).
- Interest Rate: 8.0% per annum, increasing to 14.0% upon an Event of Default.
- Repayment Terms: Notes are not repayable in cash; obligations are satisfied solely through the issuance of Common Shares upon conversion.
- Warrants Issued: Total of 321,821 warrants (228,150 + 93,671) exercisable at CAD$3.45 per share for a 5-year term.
- Revenue/Profit/Cash Flow: The filing text does not provide specific revenue, profit, operating cash flow, or margin figures for the period.
Material Changes
The primary material change is the execution of the Note Purchase Agreements on January 7 and January 20, 2026, resulting in significant new debt obligations and potential equity dilution. The First Transaction was expected to close on January 26, 2026, while the Second Transaction closed on January 21, 2026. These transactions increase the Company's leverage and outstanding share count upon conversion.
Guidance, Outlook, and Risks
Use of Proceeds: Management intends to use the net proceeds for debt repayment and general corporate purposes.
Conversion Mechanics: The conversion price is the lower of a Fixed Price ($0.29 for the First Note, $1.38 for the Second Note) or a Variable Price (90% of the lowest VWAP over 20 days), subject to Floor Prices of $0.29 and $0.275, respectively. A beneficial ownership cap of 4.99% applies.
Risks and Contingencies: The filing highlights significant risks including regulatory compliance in the cannabis industry, potential failure to meet Nasdaq listing requirements, supply chain constraints, and geopolitical risks related to conflicts in Eastern Europe and the Middle East (specifically Israel-Hamas and Israel-Iran). There is also a risk of default on existing debt and the inability to achieve sustainable profitability.
Investor Verification Checklist
- Verify the exact closing date and receipt of funds for the First Transaction (expected Jan 26, 2026).
- Confirm the current share price relative to the Fixed and Floor conversion prices to assess immediate dilution potential.
- Review the Company's existing debt load to understand the impact of the stated "debt repayment" use of proceeds.
- Monitor the status of the Form F-3 resale registration statement, which must be filed within 30 trading days.
- Assess the impact of the 4.99% beneficial ownership cap on the timing and volume of share issuance upon conversion.